Increasing the Synthetic Lethality of PARP Inhibition in Glioblastoma Cells by Depletion of Nuclear BRCA1

被引：0
|
作者：
Sizemore, S. [1 ]
Mohammad, R. [1 ]
Schnedl, B. [1 ]
Chakravarti, A. [1 ]
Xia, F. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.2258
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3450
引用
收藏
页码：S780 / S780
页数：1
相关论文
共 50 条
  • [1] Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
    Dedes, Konstantin J.
    Wilkerson, Paul M.
    Wetterskog, Daniel
    Weigelt, Britta
    Ashworth, Alan
    Reis-Filho, Jorge S.
    CELL CYCLE, 2011, 10 (08) : 1192 - 1199
  • [2] BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
    Aly, Amal
    Ganesan, Shridar
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2011, 3 (01) : 66 - 74
  • [3] Synthetic lethality of PARP inhibitors and metformin in BRCA1 intact ovarian cancer
    Hijaz, M.
    Chhina, J.
    Dar, S.
    Tebbe, C.
    Al-Wahab, Z.
    Hanna, R. K.
    Rattan, R.
    Munkarah, A. R.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 18 - 18
  • [4] 5-Hydroxymethyl-2′-deoxyuridine, but not temozolomide, enhances the selective synthetic lethality in BRCA1 and BRCA2-deficient cells caused by PARP inhibition
    Clement, Jean
    Nakamura, Jun
    CANCER RESEARCH, 2013, 73 (08)
  • [5] BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality
    Khalizieva, Anna
    Moser, Sarah C.
    Bouwman, Peter
    Jonkers, Jos
    GENES & DEVELOPMENT, 2025, 39 (1-2) : 86 - 108
  • [6] VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
    Navarro-Carrasco, Elena
    Lazo, Pedro A.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [7] Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms
    Bermes, Max
    Rodriguez, Maria Jimena
    de Toledo, Marcelo Augusto Szymanski
    Ernst, Sabrina
    Mueller-Newen, Gerhard
    Bruemmendorf, Tim Henrik
    Chatain, Nicolas
    Koschmieder, Steffen
    Baumeister, Julian
    Levantini, Elena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [8] OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells
    Baquero, Juan Miguel
    Marchena-Perea, Erik
    Mirabet, Rocio
    Torres-Ruiz, Raul
    Blanco-Aparicio, Carmen
    Rodriguez-Perales, Sandra
    Helleday, Thomas
    Benitez-Buelga, Carlos
    Benitez, Javier
    Osorio, Ana
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Differential immunomodulatory effect of PARP inhibition in BRCA1 deficient and competent tumor cells
    Alvarado-Cruz, Isabel
    Mahmoud, Mariam
    Khan, Mohammed
    Zhao, Shilin
    Oeck, Sebastian
    Meas, Rithy
    Clairmont, Kaylyn
    Quintana, Victoria
    Zhu, Ying
    Porciuncula, Angelo
    Wyatt, Hailey
    Ma, Shuangge
    Shyr, Yu
    Kong, Yong
    LoRusso, Patricia M.
    Laverty, Daniel
    Nagel, Zachary D.
    Schalper, Kurt A.
    Krauthammer, Michael
    Sweasy, Joann B.
    BIOCHEMICAL PHARMACOLOGY, 2021, 184
  • [10] Synthetic lethality between CCNE1 amplification and loss of BRCA1
    Etemadmoghadam, Dariush
    Weir, Barbara A.
    Au-Yeung, George
    Alsop, Kathryn
    Mitchell, Gillian
    George, Joshy
    Davis, Sally
    D'Andrea, Alan D.
    Simpson, Kaylene
    Hahn, William C.
    Bowtell, David D. L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (48) : 19489 - 19494
12345